A highly conserved arginine in gp120 governs HIV-1 binding to both syndecans and CCR5 via sulfated motifs.
about
Syndecan-3 is a dendritic cell-specific attachment receptor for HIV-1Role of heparan sulfate in sexually transmitted infectionsDetermining the invariant structure elements of the HIV-1 variable V3 loops: insight into the HIV-MN and HIV-Haiti isolates.Structural analysis of the HIV-1 gp120 V3 loop: application to the HIV-Haiti isolates.Sialoadhesin expressed on IFN-induced monocytes binds HIV-1 and enhances infectivity.Spermatozoa capture HIV-1 through heparan sulfate and efficiently transmit the virus to dendritic cells.Peptide ligands selected with CD4-induced epitopes on native dualtropic HIV-1 envelope proteins mimic extracellular coreceptor domains and bind to HIV-1 gp120 independently of coreceptor usageA whole genome association study of mother-to-child transmission of HIV in Malawi.A styrene-alt-maleic acid copolymer is an effective inhibitor of R5 and X4 human immunodeficiency virus type 1 infection.Syndecan-Fc hybrid molecule as a potent in vitro microbicidal anti-HIV-1 agent.Anti-gp120 minibody gene transfer to female genital epithelial cells protects against HIV-1 virus challenge in vitro.Neutralization patterns and evolution of sequential HIV type 1 envelope sequences in HIV type 1 subtype B-infected drug-naive individuals.Selective interaction of heparin with the variable region 3 within surface glycoprotein of laboratory-adapted feline immunodeficiency virusInhibition of HIV Env binding to cellular receptors by monoclonal antibody 2G12 as probed by Fc-tagged gp120.Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 use different receptor complexes to enter T cells.Identification of amino acid residues important for heparan sulfate proteoglycan interaction within variable region 3 of the feline immunodeficiency virus surface glycoprotein.The HIV matrix protein p17 promotes the activation of human hepatic stellate cells through interactions with CXCR2 and Syndecan-2.An aptamer that neutralizes R5 strains of HIV-1 binds to core residues of gp120 in the CCR5 binding site.Enhanced neutralization of HIV by antibodies displayed on the S-layer of Caulobacter crescentus.Sequence similarity between the erythrocyte binding domain of the Plasmodium vivax Duffy binding protein and the V3 loop of HIV-1 strain MN reveals a functional heparin binding motif involved in binding to the Duffy antigen receptor for chemokinesCell-free human immunodeficiency virus type 1 transcytosis through primary genital epithelial cellsThe HIV-1 envelope glycoprotein gp120 features four heparan sulfate binding domains, including the co-receptor binding site.Macroautophagy Regulation during HIV-1 Infection of CD4+ T Cells and Macrophages.Conserved changes in envelope function during human immunodeficiency virus type 1 coreceptor switchingSubtype-specific conformational differences within the V3 region of subtype B and subtype C human immunodeficiency virus type 1 Env proteins.Molecular mechanisms of FIV infection.Molecular mediators for raft-dependent endocytosis of syndecan-1, a highly conserved, multifunctional receptor.6-o- and N-sulfated syndecan-1 promotes baculovirus binding and entry into Mammalian cells.Postintegration HIV-1 infection of cervical epithelial cells mediates contact-dependent productive infection of T cells.Focus on antivirally active sulfated polysaccharides: from structure-activity analysis to clinical evaluation.gp340 promotes transcytosis of human immunodeficiency virus type 1 in genital tract-derived cell lines and primary endocervical tissue.Mutations in the feline immunodeficiency virus envelope glycoprotein confer resistance to a dominant-negative fragment of Tsg101 by enhancing infectivity and cell-to-cell virus transmission.Current and future microbicide approaches aimed at preventing HIV infection in women.Human immunodeficiency virus-1 gp120 V3 loop for anti-acquired immune deficiency syndrome drug discovery: computer-aided approaches to the problem solving.Identification of molecular sub-networks associated with cell survival in a chronically SIVmac-infected human CD4+ T cell line.Effects of mutations on HIV-1 infectivity and neutralization involving the conserved NNNT amino acid sequence in the gp120 V3 loop.Heparan sulfate proteoglycans are required for cellular binding of the hepatitis E virus ORF2 capsid protein and for viral infection.In silico design of novel broad anti-HIV-1 agents based on glycosphingolipid β-galactosylceramide, a high-affinity receptor for the envelope gp120 V3 loop.Structural requirements of glycosaminoglycans for their interaction with HIV-1 envelope glycoprotein gp120.Computational model of the HIV-1 subtype A V3 loop: study on the conformational mobility for structure-based anti-AIDS drug design.
P2860
Q24670055-58E1170C-A19A-4B10-88AF-0147C77CDC6EQ27023959-36862D9E-E419-4B0B-B12F-15EFFC8EEA2EQ30370415-1312F179-209A-44AB-8A28-635F3F555DA7Q31112947-FE3C3259-CF97-4F2A-B732-E35DE602E15FQ33328484-A4415211-A8A2-406E-A6AC-7A74E8FA1B12Q33591038-0945BEBF-CF34-4533-A847-BF4643BA73A5Q33640991-37E4CCA6-0F2C-4D82-8AC1-DE5D528298BBQ33865715-4A93F155-9842-407F-95CA-3C13ADB810A9Q33889449-F2EA3875-6563-42CA-9C16-56AB5C05EB0BQ33962742-D4D2ED21-5978-4801-BE42-99B17C366DF9Q34059643-079D26EB-5AE6-4A4A-9E08-0824904E486EQ34085098-12C960A8-0C39-4B49-97A3-EFC6C5CCFF5BQ34734101-358C5FAB-1A03-4BDA-A949-22D6956146B0Q34983331-5AEB7B1C-EEE7-4785-874B-75DCCC409EAEQ35024063-354B1FEA-8422-41B0-A10A-D4838609360EQ35077801-0F319942-D1A9-4623-A705-2D7F26E49448Q35149334-CCB16B82-7D0B-4E4A-967A-366A5AE16147Q35234289-EA2FB863-E3F1-4572-B141-3961D50A21E0Q35598601-41D880DE-4EA2-4C83-BC66-4F27F0E513ABQ35619297-FE7D92A1-0A94-4A70-9E3C-07FEB02708F2Q35634313-0F4DEBF0-CD88-40E8-8B1B-C332C96BAA40Q35674470-C3FF3C35-ADA0-4782-B39F-63A29D647655Q35939279-3108B79C-91FF-4E4C-8342-0E597578B4A1Q35947621-12250C44-71AB-4CA3-AA9C-D7E0AD5882E8Q36424523-59E48072-8282-4C3F-A4E4-8546C7B3BF43Q36692802-94FC45CD-D7B5-4F58-A53A-FDF1C89172A9Q36850197-73F1A25F-B992-4397-B0CD-0ED22AC59810Q37252596-55CDF2F6-A42D-456D-97BF-7B9F2DF81D81Q37272324-9F229401-1305-4BBF-8B6D-ED393D8AD6EAQ37278750-D2EAED82-5074-482F-A345-3E6A562BE24EQ37333741-8C1B02AE-4BD5-46E5-93ED-1B4F886EA5FFQ37619606-B94B3F01-0F6C-443E-A1B8-A1F5FA221323Q37984498-9149087B-5D60-414D-B0BD-0293691C22BBQ38014473-24D7962F-A4F1-4491-9E3F-BC9248880233Q38962390-40CF8F6C-5391-4C54-8A55-9B435F8986E6Q39362848-43719FCE-B443-4785-B8B1-6C5E3D872ACEQ39790232-C34F6022-4CCA-4657-842A-3498DEBFC091Q42211561-B3801CF6-056F-4561-92B2-AFF9B145B5FFQ42268696-60BA5B32-983B-4207-966A-BF72F69DD968Q44111505-1B0F8D0C-003C-4009-9302-108188BF7B31
P2860
A highly conserved arginine in gp120 governs HIV-1 binding to both syndecans and CCR5 via sulfated motifs.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
A highly conserved arginine in ...... and CCR5 via sulfated motifs.
@en
type
label
A highly conserved arginine in ...... and CCR5 via sulfated motifs.
@en
prefLabel
A highly conserved arginine in ...... and CCR5 via sulfated motifs.
@en
P2093
P2860
P356
P1476
A highly conserved arginine in ...... and CCR5 via sulfated motifs.
@en
P2093
Anju Chatterji
Aymeric de Parseval
Guido David
John H Elder
Michael D Bobardt
Philippe A Gallay
Susan Zolla-Pazner
Tun-Hou Lee
Udayan Chatterji
P2860
P304
39493-39504
P356
10.1074/JBC.M504233200
P407
P577
2005-09-12T00:00:00Z